First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Shares Down 1.7% – Time to Sell?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) dropped 1.7% during trading on Thursday . The company traded as low as $33.95 and last traded at $34.00. Approximately 1,467 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 7,671 shares. The stock had previously closed at $34.59.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The stock’s fifty day moving average price is $34.14 and its 200 day moving average price is $33.25. The stock has a market capitalization of $30.60 million, a P/E ratio of 14.51 and a beta of 0.47.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Thursday, March 26th were issued a $0.0573 dividend. The ex-dividend date was Thursday, March 26th. This represents a $0.23 dividend on an annualized basis and a dividend yield of 0.7%.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Hedge funds have recently added to or reduced their stakes in the business. NBC Securities Inc. lifted its stake in First Trust Nasdaq Pharmaceuticals ETF by 33.0% in the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after acquiring an additional 329 shares during the period. Raymond James Financial Inc. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth about $57,000. Kestra Advisory Services LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at about $59,000. Flagship Harbor Advisors LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at about $205,000. Finally, Stratos Wealth Partners LTD. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter valued at about $230,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.